What's new in the treatment of chronic hand eczema?

被引：0

作者：

Halioua, B. ^{[1
]}

Crepy, M. -N. ^{[2
]}

机构：

[1] Inst Alfred Fournier, F-75014 Paris, France

[2] Grp Hosp Cochin St Vincent de Paul, Serv Pathol Profess, AP HP, Paris, France

来源：

REVUE FRANCAISE D ALLERGOLOGIE | 2010年 / 50卷 / 07期

关键词：

Chronic hand eczema; Treatment; Corticosteroids; Phototherapy; Alitretinoin; SECONDARY INDIVIDUAL PREVENTION; PIMECROLIMUS CREAM 1-PERCENT; DOUBLE-BLIND; TACROLIMUS OINTMENT; LONG-TERM; TOPICAL BETAMETHASONE-17,21-DIPROPIONATE; RECALCITRANT DERMATOSES; ATOPIC-DERMATITIS; UVB PHOTOTHERAPY; UVA1; IRRADIATION;

D O I：

10.1016/j.reval.2010.05.001

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Eczema, the most frequent skin disease affecting the hands, tends to be recurrent and chronic. Prevention of hand eczema is based on the identification and avoidance of predisposing factors together with the use of protective measures for the hands (moisturizers, gloves). Topical corticosteroids, particularly the highly potent class 1 type, and localized phototherapy (localized PUVA therapy and UVB phototherapy) constitute the first-line treatment in the management of chronic hand eczema (CHE). Alitretinoin is a new treatment which may be indicated in severe CHE not responding to potent topical corticosteroids. (C) 2010 Elsevier Masson SAS. All rights reserved.

引用

页码：549 / 555

页数：7

共 50 条

[21] Management of Chronic Hand Eczema
de Leon, F. J.
Berbegal, L.
Silvestre, J. F.
ACTAS DERMO-SIFILIOGRAFICAS, 2015, 106 (07): : 533 - 544
[22] Alitretinoin is not a suitable treatment for the majority of chronic hand eczema patients
Lefevre, Marine-Alexia
Tauber, Marie
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025, 39 (02) : 261 - 262
[23] Alitretinoin is well tolerated in the treatment of severe chronic hand eczema
Bissonnette, Robert
Maares, Jurgen
Shear, Neil
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB51 - AB51
[24] Management of chronic hand eczema
Diepgen, Thomas L.
Agner, Tove
Aberer, Werner
Berth-Jones, John
Cambazard, Frederic
Elsner, Peter
McFadden, John
Coenraads, Pieter Jan
CONTACT DERMATITIS, 2007, 57 (04) : 203 - 210
[25] Management of chronic hand eczema
Batycka-Baran, Aleksandra
Baran, Wojciech
Szepietowski, Jacek
POSTEPY DERMATOLOGII I ALERGOLOGII, 2009, 26 (02): : 84 - 91
[26] Management of chronic hand eczema
Lahfa, M.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2014, 141 (01): : S143 - S150
[27] Current emerging and investigational drugs for the treatment of chronic hand eczema
Cheng, Julia
Facheris, Paola
Ungar, Benjamin
Guttman-Yassky, Emma
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (08) : 843 - 853
[28] Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges
Dubin, Celina
Del Duca, Ester
Guttman-Yassky, Emma
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2020, 16 : 1319 - 1332
[29] CHRONIC HAND ECZEMA STRATEGIES
SHELLEY, WB
SHELLEY, ED
CUTIS, 1982, 29 (06): : 569 - &
[30] Oral Toctino launched for treatment of severe chronic hand eczema
Dawber, Steve
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (11) : 612 - 612

← 1 2 3 4 5 →